NEW HAVEN, CT
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)YALE NEW HAVEN HOSPITAL, founded in 1826, is a large national nonprofit in the Health Care sector that reported $4.6B in total revenue in fiscal year 2023. Revenue grew 9% year-over-year, indicating healthy expansion. Expenses of $4.4B left a modest 4% surplus.
THE MISSION OF YNHH IS TO PROVIDE INNOVATIVE AND EXCELLENT PATIENT CARE, TEACHING, RESEARCH, AND SERVICE TO THE COMMUNITIES IT SERVES.
YALE NEW HAVEN HOSPITAL (YNHH) IS A NATIONALLY RECOGNIZED, 1,541-BED, NOT-FOR-PROFIT HOSPITAL SERVING AS THE PRIMARY TEACHING HOSPITAL FOR THE YALE SCHOOL OF MEDICINE. THE HOSPITAL HAS TWO NEW...
YALE NEW HAVEN HOSPITAL (YNHH) IS A NATIONALLY RECOGNIZED, 1,541-BED, NOT-FOR-PROFIT HOSPITAL SERVING AS THE PRIMARY TEACHING HOSPITAL FOR THE YALE SCHOOL OF MEDICINE. THE HOSPITAL HAS TWO NEW HAVEN-BASED CAMPUSES, AND INCLUDES YALE NEW HAVEN CHILDREN'S HOSPITAL, YALE NEW HAVEN PSYCHIATRIC HOSPITAL AND SMILOW CANCER HOSPITAL. YNHH HAS RECEIVED MAGNET DESIGNATION FROM THE AMERICAN NURSES CREDENTIALING CENTER, THE NATION'S HIGHEST HONOR OF NURSING EXCELLENCE. YNHH HAS A COMBINED MEDICAL STAFF OF OVER 5,000 UNIVERSITY AND COMMUNITY PHYSICIANS PRACTICING IN MORE THAN 100 SPECIALTIES. THE HOSPITAL'S HEART AND VASCULAR CENTER'S NUCLEAR CARDIOLOGY SERVICES ARE NOW BOLSTERED WITH A NEW DIGITAL PET/CT SCANNER THAT USES LOW RADIATION, PROVIDES NOVEL IMAGING STUDIES FOR DIFFERENT TYPES OF CORONARY ARTERY DISEASE AND VASCULAR DISEASE, AND ASSESSES HEART ARTERY CALCIUM, A MARKER OF CORONARY ARTERY DISEASE. THE HEART AND VASCULAR CENTER ALSO ADDED A SINGLE-PLANE ANGIOGRAPHY UNIT AT YALE NEW HAVEN HOSPITAL'S SAINT RAPHAEL CAMPUS. THE UNIT, USED FOR COMPLEX INTERVENTIONAL RADIOLOGY PROCEDURES, SUPPORTS IMAGE-GUIDED, NON-SURGICAL TREATMENTS. THIS APPROACH OFTEN REDUCES THE NEED FOR TRADITIONAL SURGERY. SMILOW CANCER HOSPITAL AT YALE NEW HAVEN HOSPITAL INTRODUCED A REVOLUTIONARY NEW TYPE OF RADIATION THERAPY TO TREAT LUNG AND BONE CANCERS. REFLEXION MEDICAL'S SCINTIX BIOLOGY-GUIDED RADIOTHERAPY (BGRT) TECHNOLOGY IS THE ONLY CANCER TREATMENT THAT USES SIGNALS PRODUCED BY A TUMOR TO PRECISELY DIRECT RADIATION WITHOUT HARMING HEALTHY TISSUE. BGRT IS SAFE, EFFECTIVE WITH FEWER SESSIONS, AND CAN BE COMBINED WITH CHEMOTHERAPY, IMMUNOTHERAPY AND TARGETED DRUGS TO TAILOR THE BEST THERAPEUTIC PLAN FOR EACH PATIENT'S SPECIFIC SITUATION. A SURVEY TOOL DEVELOPED BY YALE NEW HAVEN PSYCHIATRIC HOSPITAL FOR BEHAVIORAL HEALTH INPATIENTS RECEIVED ATTENTION FROM THE CENTERS FOR MEDICARE AND MEDICAID SERVICES, WHICH INCORPORATED THE SURVEY INTO ITS NATIONWIDE INPATIENT PSYCHIATRIC FACILITY QUALITY REPORTING PROGRAM. THE TEAM IDENTIFIED FOUR FACTORS INTEGRAL TO INPATIENTS' EXPERIENCE: TREATMENT TEAM RELATIONSHIPS, NURSING TEAM PRESENCE, TREATMENT EFFECTIVENESS AND HEALING ENVIRONMENT. THE SURVEY TOOL ALSO WAS RECOGNIZED WITH THE 2024 AMERICAN NURSES CREDENTIALING CENTER MAGNET PRIZE. IN 2026, THE SURVEY WILL BE REQUIRED FOR USE IN MORE THAN 1,600 INPATIENT BEHAVIORAL HEALTH FACILITIES NATIONWIDE THAT PARTICIPATE IN THE CMS QUALITY REPORTING PROGRAM. THE PULMONARY EMBOLISM RESPONSE TEAM CONSORTIUM, A LEADING AUTHORITY IN PULMONARY EMBOLISM CARE, DESIGNATED YALE NEW HAVEN HOSPITAL AS ONE OF THE FIRST OF THREE PULMONARY EMBOLISM COMPREHENSIVE CARE CENTERS OF EXCELLENCE IN THE WORLD. YALE NEW HAVEN HOSPITAL SUCCESSFULLY COMPLETED A RIGOROUS APPLICATION PROCESS AND DEMONSTRATED COMMITMENT TO EXCEPTIONAL, EVIDENCE-BASED CARE FOR PATIENTS WITH PULMONARY EMBOLISM. YALE NEW HAVEN HOSPITAL RECEIVED THE 2024 IPRO QUALITY AWARD FOR SIGNIFICANT ACHIEVEMENTS IN IMPROVING HEALTHCARE QUALITY. THE IPRO QUALITY INNOVATION NETWORK-QUALITY IMPROVEMENT ORGANIZATION IS A FEDERAL PROGRAM FOCUSED ON IMPROVING THE QUALITY OF CARE PROVIDED TO MEDICARE PATIENTS ACROSS THE UNITED STATES. U.S. NEWS & WORLD REPORT RECOGNIZED YALE NEW HAVEN HEALTH'S GRIMES CENTER AS "HIGH PERFORMING" FOR SHORT STAYS BASED ON THE QUALITY OF CARE A NURSING HOME PROVIDES PATIENTS WHO HAVE BEEN RELEASED FROM THE HOSPITAL AFTER A STROKE, HEART ATTACK, INFECTION, ACCIDENTAL INJURY OR OTHER CONDITIONS. THE CONNECTICUT HOSPITAL ASSOCIATION AND CONNECTICUT DEPARTMENT OF PUBLIC HEALTH AWARDED YALE NEW HAVEN HOSPITAL THE 2024 CONNECTICUT'S HOSPITAL COMMUNITY SERVICE AWARD FOR THEIR MEDICAL-LEGAL PARTNERSHIP PROJECT, WHICH SUCCESSFULLY ADDRESSED LEGAL NEEDS THAT IMPACT HEALTH IN HOUSING, EDUCATIONAL ENTITLEMENTS, DISABILITY RIGHTS AND PUBLIC BENEFITS. YALE NEW HAVEN HOSPITAL, AS AN URBAN MEDICAL CENTER, IS THE BUSIEST PROVIDER OF PATIENT CARE SERVICES IN THE REGIONS, CARING FOR THE LARGEST NUMBER OF MEDICAID-COVERED AND UNINSURED PATIENTS IN THE STATE. IN ADDITION, THE HOSPITAL SPONSORS AND PARTICIPATES IN NUMEROUS PROGRAMS AND ACTIVITIES TO BENEFIT THE PEOPLE OF NEW HAVEN AND SURROUNDING COMMUNITIES. AS PART OF THE HOSPITAL MISSION TO PROMOTE HEALTH AND WELLNESS THROUGHOUT THE GREATER NEW HAVEN REGION, THE HOSPITAL SPONSORS, DEVELOPS AND PARTICIPATES IN A WIDE VARIETY OF COMMUNITY-BASED PROGRAMS AND SERVICES ADDRESSING CAREER DEVELOPMENT, FINANCIAL ASSISTANCE PROGRAMS, SCHOOL-BASED HEALTH CENTERS, WOMEN AND CHILDREN'S SERVICES, AND A WELLNESS INFORMATION NETWORK. PART I, LINE 4 & PART VI, LINE 1B NUMBER OF INDEPENDENT VOTING MEMBERS OF THE GOVERNING BODY THE ORGANIZATION SOUGHT TO CONFIRM THE INDEPENDENCE OF EACH VOTING MEMBER OF ITS GOVERNING BODY BY REQUESTING THAT EACH SUCH VOTING MEMBER RESPOND TO A QUESTIONNAIRE CONTAINING THE PERTINENT INSTRUCTIONS AND DEFINITIONS AND DESIGNED TO ELICIT THE INFORMATION NECESSARY TO DETERMINE INDEPENDENCE. IN THE EVENT THAT THE ORGANIZATION DOES NOT RECEIVE A RESPONSE FROM ANY SUCH VOTING MEMBER, THE ORGANIZATION REVIEWS OTHER INFORMATION KNOWN TO IT REGARDING THE VOTING MEMBER AND MAKES A REASONABLE ASSESSMENT OF INDEPENDENCE BASED ON THAT INFORMATION.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $4,571,807,805 | $4,190,091,426 | +0.1% |
| Expenses | $4,367,597,575 | $4,112,468,772 | +0.1% |
| Net Income | $204,210,230 | $77,622,654 | +1.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MARNA BORGSTROM | FORMER OFFICER | 0.00 |
|
$3,123,075 | $0 | $5,277,125 |
| KEITH CHURCHWELL | FORMER OFFICER (CURRENT YR COMP) | 0.00 |
|
$0 | $316,857 | $3,186,928 |
| KEITH CHURCHWELL | FORMER OFFICER (VESTED DEFERRED) | 0.00 |
|
$0 | $0 | $1,075,650 |
| CHRISTOPHER O'CONNOR | CEO/TRUSTEE (CURRENT YR COMP) | 1.00 |
Director
|
$0 | $822,667 | $3,860,836 |
| CHRISTOPHER O'CONNOR | CEO/TRUSTEE (VESTED DEFERRED) | 1.00 |
Director
|
$0 | $0 | $265,120 |
| VINCENT TAMMARO | FORMER OFFICER | 0.00 |
|
$0 | $0 | $2,644,092 |
| MICHAEL HOLMES | EVP/COO (CURRENT YR COMP) | 40.00 |
Key Emp
|
$789,720 | $312,679 | $1,102,399 |
| MICHAEL HOLMES | EVP/COO (VESTED DEFERRED) | 40.00 |
Key Emp
|
$937,596 | $0 | $937,596 |
| PAMELA SUTTON-WALLACE | EVO, COO, INT PRES, TRUSTEE | 1.00 |
Officer
Director
|
$0 | $582,147 | $2,254,274 |
| LORI PICKENS | SVP (CURRENT YR COMP) | 40.00 |
Key Emp
|
$683,667 | $139,838 | $823,505 |
| LORI PICKENS | SVP (VESTED DEFERRED) | 40.00 |
Key Emp
|
$483,146 | $0 | $483,146 |
| WILLIAM ASELTYNE | ASSOC SEC (CURRENT YR COMP) | 1.00 |
Officer
|
$0 | $193,425 | $1,450,910 |
| WILLIAM ASELTYNE | ASSOC SEC (VESTED DEFERRED) | 1.00 |
Officer
|
$0 | $0 | $235,138 |
| GAIL KOSYLA | EVP/CFO/TREASURER | 1.00 |
Officer
|
$0 | $407,968 | $1,543,615 |
| CYNTHIA SPARER | EVP | 38.00 |
Key Emp
|
$987,135 | $48,034 | $1,035,169 |
| ALAN FRIEDMAN | SVP/CMO | 40.00 |
Key Emp
|
$698,785 | $226,444 | $925,229 |
| FRANCINE LORUSSO | SVP | 40.00 |
Key Emp
|
$697,497 | $217,919 | $915,416 |
| THOMAS DONAHUE | VP | 40.00 |
Highest
|
$851,247 | $48,229 | $899,476 |
| KEVIN A MYATT | FORMER OFFICER | 0.00 |
|
$0 | $0 | $379,589 |
| ENA WILLIAMS | SVP/CNO | 40.00 |
Key Emp
|
$626,868 | $58,141 | $685,009 |
| MICHAEL SCHAFFER | VP | 40.00 |
Highest
|
$632,412 | $24,206 | $656,618 |
| MICHAEL LOFTUS | FORMER KEY EMPLOYEE | 0.00 |
|
$439,670 | $36,938 | $476,608 |
| KEVIN VEST | VP | 40.00 |
Highest
|
$489,958 | $50,327 | $540,285 |
| STEPHEN VYCE | CHIEF DEPT OF PODIATRY | 40.00 |
Highest
|
$479,861 | $63,049 | $542,910 |
| CHRISTIN BROOKS-MARK | CRNA | 40.00 |
Highest
|
$527,000 | $62,864 | $589,864 |
| KEVIN WALSH | FORMER OFFICER | 0.00 |
|
$150,661 | $0 | $196,166 |
| RICHARD D'AQUILA | FORMER OFFICER | 0.00 |
|
$0 | $0 | $196,168 |
| JONI HANSSON | TRUSTEE | 1.00 |
Director
|
$39,520 | $0 | $39,520 |
| NITA AHUJA | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| VICTOR BOLDEN | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| NANCY BROWN | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| VINCENT CALARCO | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| KERWIN CHARLES | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| ERIK CLEMONS | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| JOCELYN CUNNINGHAM | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES ELROD | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| AZITA EMAMI | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| MARY FARRELL | CHAIRMAN/TRUSTEE | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| WILLIAM GINSBERG | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| KATHERINE HEILPERN | PRESIDENT/TRUSTEE | 40.00 |
Officer
Director
|
$0 | $0 | $0 |
| AARON HOLLANDER | SECRETARY/TRUSTEE | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| THOMAS B KETCHUM | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| MARIETTA LEE | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| LINDA KOCH LORIMER | VICE CHAIR/TRUSTEE | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SISTER ROSEMARY MOYNIHAN | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| STEPHEN MURPHY | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| MEGAN L RANNEY MD | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| PETER SALOVEY | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL TAYLOR | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES TORGERSON | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| EUGENIA VINING | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| PATRICIA WILBER | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $4,571,807,805 | $4,367,597,575 | $5,447,832,318 | $204,210,230 |
| 2023 | $4,190,091,426 | $4,112,468,772 | $4,636,988,989 | $77,622,654 |
| 2022 | $3,904,285,739 | $3,968,389,537 | $4,808,074,993 | $-64,103,798 |
| 2021 | $3,722,110,705 | $3,586,304,261 | $5,389,749,261 | $135,806,444 |
| 2020 | $3,414,587,874 | $3,353,235,179 | $4,903,006,397 | $61,352,695 |
| 2019 | $3,266,220,524 | $3,007,841,706 | $4,163,506,332 | $258,378,818 |
| 2018 | $3,119,994,657 | $2,767,594,128 | $3,869,962,766 | $352,400,529 |
Compare YALE NEW HAVEN HOSPITAL with other nonprofits in Connecticut and across the country.